The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
The Lead
AstraZeneca Selects Location for New Global R&D Centre and Corporate Headquarters in Cambridge, UK
June 18, 2013 9:03 am | News | Comments
AstraZeneca today announced that its new UK-based global research and development centre and corporate headquarters will be located at the Cambridge Biomedical Campus on the southern outskirts of the city. By 2016, the new site will house a highly-skilled workforce of approximately 2,000.
Royalty Pharma Lets Elan Takeover Bid Expire
June 18, 2013 9:37 am | by TOM MURPHY,AP Business Writer | News | Comments
Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse...
BioScrip Buying Drug Infusion Company for $223M
June 17, 2013 1:42 pm | by The Associated Press | News | Comments
BioScrip Inc. plans to expand its drug infusion business with a $223 million acquisition of...
Teva Pharma Buying MicroDose Therapeutx for $40M
June 17, 2013 1:25 pm | by The Associated Press | News | Comments
Teva Pharmaceutical Industries Ltd. said Monday that it is buying MicroDose Therapeutx for $40...
FREE Daily Email Newsletter
Disposable Respirators
June 18, 2013 3:47 pm | Product Releases | CommentsTruAir’s broad-spectrum protection — NIOSH approved N95, N99, and P100 level protection — have made the entire TruAir line extremely popular in myriad industries. TruAir and TruAir Plus, NIOSH approved N95 and N99-level protection respectively, feature a similar design with a large, molded shell to aid in the reduction of breathing resistance.
Blister Package
June 18, 2013 3:30 pm | Product Releases | CommentsThe "smart" blister package, Ecoslide-RX® with integrated Med-ic® technology is senior friendly and child-resistant. Ideal for clinical trials where dosing data should be precisely recorded, Ecoslide-RX with Med-ic incorporates an electronic module and printed sensor grid inside the package, both of which are invisible to the patient.
Tablet Counter
June 18, 2013 3:12 pm | Product Releases | CommentsThe PPS SuperCount is a tablet counter operating at speeds up to 160 bottles per minute (24 track counter), and the new design features maximize efficiency while minimizing downtime. The vibrator trays have been redesigned to make them lighter which results in better response to vibration and faster, smoother product movement into the count eyes for a more precise product feed.
Ribbon Blenders
June 18, 2013 2:28 pm | Product Releases | CommentsOver 80 ribbon blenders, sized for different working volumes and bulk densities, are now available. Built-to-order custom units are also offered with fast lead times like the pictured 10-cu.ft. sanitary ribbon blender featuring 150-grit stainless steel 316 internal and external surfaces, bottom discharge extruder, lantern rings, spray bar system with atomizing nozzles, load cells and a NEMA 4X Ross SysCon control panel.
Dry Scroll Vacuum Pumps
June 18, 2013 11:54 am | Product Releases | CommentsThe nXDS-C features the Chemraz® exhaust valve which is used for applications involving pumping organic solvents or other materials that may attack the standard pumps’ fluroelastomer exhaust valve, causing it to deteriorate rapidly.
AMRI Burlington Receives DEA Approval to Handle Controlled Substances
June 18, 2013 10:59 am | News | CommentsAMRI announced today that its Burlington, Mass., site has received approval to expand its current U.S. Drug Enforcement Administration (DEA) registration to handle Schedule 2 and 2N controlled substances. The license represents the DEA’s acknowledgement of Burlington’s physical security and quality systems, including inventory control and documentation.
Preparing for a Pandemic
June 18, 2013 8:29 am | Videos | CommentsMary Mahoney, North Shore Long Island Jewish Medical director of Emergency Planning and Preparedness, discusses the steps her hospital system is taking to prepare for a possible pandemic. In light of recent outbreaks around the globe pandemic preparation is becoming more important than ever.
Royalty Pharma Announces Withdrawal of Judicial Review and Lapse of Offer
June 18, 2013 8:11 am | News | CommentsRoyalty Pharma announced today that it had withdrawn its request for a judicial review of the Irish Takeover Panel's decision requiring it to lapse its offer for Elan Corporation, plc if, among other things, Elan shareholders approved the Share Repurchase Program.
Report: Slowdown in Health Care Costs to Continue
June 18, 2013 8:07 am | by RICARDO ALONSO-ZALDIVAR,Associated Press | News | CommentsThere's good news for most companies that provide health benefits for their employees: America's slowdown in medical costs may be turning into a trend, rather than a mere pause. A report Tuesday from accounting and consulting giant PwC projects lower overall growth in medical costs for next year, even as the economy gains strength and millions of uninsured people receive coverage under President Barack Obama's health care law.
Valeant Pharma Plans $1.75B Stock Offering
June 17, 2013 4:53 pm | by The Associated Press | News | CommentsCanadian drugmaker Valeant Pharmaceuticals International Inc. said Monday it will sell $1.75 billion in stock to help fund its acquisition of Bausch + Lomb. Valeant did not say how many shares it plans to sell. The company said it plans to raise $1.75 billion before discounts, expenses, and other...
LED Warning Lights
June 17, 2013 2:25 pm | Product Releases | CommentsThe LFH Series LED warning lights produce a high-visibility, 110 flashes-per-minute strobe beacon light suitable for virtually any industrial application: indoor or outdoor, day or night, rain or shine, hot or cold.
Globus Faces $16M Payment over Patent Dispute
June 17, 2013 1:59 pm | by The Associated Press | News | CommentsSpinal implant manufacturer Globus Medical may have to pay $16 million after a jury decided that three of its products infringed on the patents held by DePuy Synthes Products LLC, a unit of Johnson & Johnson Inc. Globus said that the jury in the U.S. District Court in Delaware made its...
Perrigo Acquires Eye-Care Portfolio from Fera
June 17, 2013 11:15 am | by The Associated Press | News | CommentsPerrigo Co. said Monday that it bought the ophthalmic ointment and solution portfolio of Fera Pharmaceuticals LLC for $93 million in cash. Perrigo has been looking for an ophthalmic deal as part of its strategy to expand its presence in the niche topical medication market. The company also...
US: 'Pay to Delay' Generic Drugs Can Be illegal
June 17, 2013 10:58 am | by JESSE J. HOLLAND - Associated Press - Associated Press | News | CommentsThe Supreme Court ruled Monday that deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can be sometimes be illegal and therefore challenged by federal officials in court. The justices voted...
J&J to Buy Aragon For at Least $650M
June 17, 2013 10:08 am | by The Associated Press | News | CommentsJohnson & Johnson said Monday that it has agreed to buy Aragon Pharmaceuticals Inc. for at least $650 million in cash, boosting its position in prostate drug development. The privately-held San Diego, company is focused on the development of drugs to treat hormonally-driven cancers. Under...
